AKERO THERAPEUTICS INC

CUSIP: 00973Y108 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 103,239 Value ($000) $4,902 Avg Close Range
Q2 2025
Shares 107,438 Value ($000) $5,733 Avg Close Range
Q1 2025
Shares 110,687 Value ($000) $4,481 Avg Close Range
Q4 2024
Shares 105,686 Value ($000) $2,940 Avg Close Range
Q3 2024
Shares 104,376 Value ($000) $2,995 Avg Close Range
Q2 2024
Shares 107,338 Value ($000) $2,518 Avg Close Range
Q1 2024
Shares 82,398 Value ($000) $2,081 Avg Close Range
Q4 2023
Shares 70,699 Value ($000) $1,651 Avg Close Range
Q3 2023
Shares 70,784 Value ($000) $3,580 Avg Close Range
Q2 2023
Shares 61,174 Value ($000) $2,856 Avg Close Range
Q1 2023
Shares 54,871 Value ($000) $2 Avg Close Range
Q4 2022
Shares 51,713 Value ($000) $3 Avg Close Range
Q3 2022
Shares 42,261 Value ($000) $1,439 Avg Close Range
Q2 2022
Shares 39,586 Value ($000) $374 Avg Close Range
Q1 2022
Shares 26,420 Value ($000) $375 Avg Close Range
Q4 2021
Shares 25,655 Value ($000) $543 Avg Close Range
Q3 2021
Shares 26,201 Value ($000) $586 Avg Close Range
Q2 2021
Shares 25,026 Value ($000) $621 Avg Close Range
Q1 2021
Shares 13,650 Value ($000) $396 Avg Close Range
Q4 2020
Shares 14,400 Value ($000) $372 Avg Close Range
Q3 2020
Shares 13,130 Value ($000) $404 Avg Close Range
Q2 2020
Shares 11,446 Value ($000) $285 Avg Close Range